Rivera-Rivera, Yainyrette
Vargas, Geraldine
Jaiswal, Neha
Núñez-Marrero, Angel
Li, Jiannong
Chen, Dung-Tsa
Eschrich, Steven
Rosa, Marilin
Johnson, Joseph O.
Dutil, Julie
Chellappan, Srikumar P.
Saavedra, Harold I.
Funding for this research was provided by:
National Cancer Institute (PSM-U54-CA163071/MCC-U54-CA163068, P30-CA076292, PSM-U54-CA163071/MCC-U54-CA163068)
Puerto Rico Science, Technology and Research Trust (Advanced Grant)
National Institutes of Health (2U54MD007587)
Article History
Received: 2 March 2022
Accepted: 29 November 2022
First Online: 9 December 2022
Declarations
:
: Immunostaining breast cancer tissue samples were done under the IRB protocol 160115-HS<i>.</i> De-identified data and biospecimens were obtained from the U56/U56’s Puerto Rico Biobank from previously consented patients through the IRB protocol 080121-IF.
: The authors declare that they have no competing interests.